Want to see JP:4202 full AI Analyst Report?
Top Page
Daicel
(4202)
Select Model
Select Model
Rating:55Neutral
Price Target:
¥1,438.00
▲(15.27% Upside)
Action:Reiterated
Date:05/23/26
The score is primarily held back by weaker recent profitability and inconsistent free cash flow despite steady revenue growth and a gradually improving balance sheet. Technical indicators also point to a broader downtrend. The main offset is an attractive dividend yield, though the negative P/E signals current earnings pressure.
Positive Factors
Consistent Revenue Growth
Sustained top-line expansion across cycles indicates durable demand for Daicel’s products and supports scale benefits. A constructive revenue trajectory underpins long-term investment capacity and market position even if margins ebb, helping fund R&D and capital expenditure required for specialty product leadership.
Negative Factors
Weakening Profitability
A marked decline in net income and compressed operating margins signal structural margin pressure from cost inputs or mix shifts. Persistent profitability weakness undermines reinvestment ability, dividend sustainability and credit metrics, raising the bar for operational fixes to restore long-term earnings durability.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained top-line expansion across cycles indicates durable demand for Daicel’s products and supports scale benefits. A constructive revenue trajectory underpins long-term investment capacity and market position even if margins ebb, helping fund R&D and capital expenditure required for specialty product leadership.
Read all positive factors
Daicel (4202) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥357.00B
Dividend Yield4.27%
Average Volume (3M)536.76K
Price to Earnings (P/E)36.2
Beta (1Y)1.06
Revenue Growth-1.18%
EPS Growth-80.61%
CountryJP
Employees11,134
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)38.74
Shares Outstanding256,142,670
10 Day Avg. Volume480,400
30 Day Avg. Volume536,760
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.91
Price to Sales (P/S)0.56
P/FCF Ratio128.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,500.00Price Target Upside20.24% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)130.13
Revenue Forecast (FY)¥609.07B
Daicel Business Overview & Revenue Model
Company Description
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic de...
How the Company Makes Money
Daicel makes money primarily by manufacturing and selling chemical and materials products (largely B2B) and related components, with revenue recognized through product shipments under supply contracts and purchase orders. Key revenue streams inclu...
Daicel Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
58
Neutral
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 579.63B | 586.53B | 558.06B | 538.03B | 467.94B |
| Gross Profit | 146.29B | 165.84B | 160.39B | 147.04B | 139.68B |
| EBITDA | 72.71B | 108.86B | 111.40B | 87.97B | 75.84B |
| Net Income | 10.18B | 49.48B | 55.84B | 40.68B | 31.25B |
Balance Sheet | |||||
| Total Assets | 833.93B | 813.83B | 839.17B | 765.61B | 698.84B |
| Cash, Cash Equivalents and Short-Term Investments | 68.81B | 65.14B | 73.18B | 93.84B | 90.53B |
| Total Debt | 304.25B | 286.12B | 304.12B | 321.97B | 283.55B |
| Total Liabilities | 463.55B | 438.79B | 464.30B | 455.17B | 419.29B |
| Stockholders Equity | 355.60B | 359.99B | 358.90B | 295.21B | 272.02B |
Cash Flow | |||||
| Free Cash Flow | 2.51B | 23.44B | 11.11B | -20.54B | -501.00M |
| Operating Cash Flow | 67.84B | 93.41B | 76.73B | 26.85B | 42.99B |
| Investing Cash Flow | -49.26B | -47.87B | -55.37B | -36.89B | -46.53B |
| Financing Cash Flow | -21.26B | -48.85B | -52.37B | 12.76B | -5.45B |
Daicel Technical Analysis
Positive
1247.50
Price Trends
1295.66
Positive
1330.17
Positive
1336.57
Positive
Market Momentum
32.35
Negative
60.66
Neutral
57.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4202, the sentiment is Positive. The current price of 1247.5 is below the 20-day moving average (MA) of 1366.45, below the 50-day MA of 1295.66, and below the 200-day MA of 1336.57, indicating a bullish trend. The MACD of 32.35 indicates Negative momentum. The RSI at 60.66 is Neutral, neither overbought nor oversold. The STOCH value of 57.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4202.
Daicel Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥586.80B | 23.20 | 6.52% | 1.82% | 4.95% | 52.93% | |
73 Outperform | ¥340.83B | 11.20 | 5.47% | 3.41% | 0.55% | 26.28% | |
73 Outperform | ¥437.43B | 12.05 | 9.59% | 3.91% | -2.06% | 46.39% | |
67 Neutral | ¥308.94B | 12.81 | 1.47% | 4.29% | -5.02% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥903.82B | -22.63 | -2.50% | 3.49% | -4.57% | -190.44% | |
55 Neutral | ¥357.00B | 36.20 | 9.34% | 4.27% | -1.18% | -80.61% |
* Basic Materials Sector Average
JP:4202
Daicel
1,402.50
210.08
17.62%
JP:4118
Kaneka
5,626.00
1,714.99
43.85%
JP:4182
Mitsubishi Gas Chemical Company
4,685.00
2,334.76
99.34%
JP:4208
UBE Industries
3,147.00
950.22
43.26%
JP:4205
Zeon
2,249.00
761.79
51.22%
JP:4203
Sumitomo Bakelite Co., Ltd.
7,200.00
3,091.44
75.24%
Daicel Corporate Events
Daicel Lowers EBITDA Growth Target in Revised Mid-Term Strategy
May 25, 2026
Daicel Corporation has issued corrections to its recently announced mid-term management strategy, Accelerate 2030, adjusting a key performance target for its growth portfolio. The company revised its EBITDA growth goal for the period from the fisc...
Daicel Lifts Dividend Forecast and Sharpenes Shareholder Return Targets
May 22, 2026
Daicel has revised its dividend forecast for the fiscal year ending March 2027, lifting the planned annual dividend to ¥70 per share, up from ¥60 in the previous year. The payout will be split evenly between an interim dividend of ¥...
Daicel Launches Accelerate 2030 Strategy to Bolster Profitability and Growth
May 22, 2026
Daicel has unveiled its new mid-term management strategy, Accelerate 2030, aimed at reinforcing safety and operational stability while strengthening its earnings structure. The plan targets stable profitability in its material business, enhanced r...
Daicel Introduces Performance-Based Stock Plan for Directors to Align Pay with Long-Term Goals
May 12, 2026
Daicel Corporation has approved the introduction of a performance-based stock compensation plan for its internal directors, aiming to align their interests more closely with shareholders and to incentivize sustainable growth in corporate value. Th...
Daicel to Cancel 4.05% of Outstanding Shares to Tighten Capital Base
May 12, 2026
Daicel Corporation’s board has approved the cancellation of 10,800,000 shares of its common stock, representing 4.05% of shares outstanding prior to the move. Following the cancellation, scheduled for May 21, 2026, the company’s total ...
Daicel Profit Plunges on Materials Weakness and Plant Impairment
May 12, 2026
Daicel reported a 1.2% decline in net sales to 579.6 billion yen for the year ended March 2026, with operating income falling 31% to 42.1 billion yen and EBITDA down 16.6%. Profit attributable to owners of the parent plunged 79.4% to 10.2 billion ...
Daicel Profit Slumps but Dividend Held as Company Signals Modest Recovery in FY2027
May 12, 2026
Daicel Corporation reported a 1.2% decline in consolidated net sales to ¥579.6 billion for the year ended March 31, 2026, with operating profit down 31% to ¥42.1 billion and profit attributable to owners of the parent plunging 79.4% to &...
Daicel Books Large Guarantee Provision as It Receives Major Dividend from Subsidiaries
May 11, 2026
Daicel Corporation has received a dividend of 10.95 billion yen from its consolidated subsidiary Daicel (China) Investment Co., Ltd., which was resolved in late January and paid in February, and this income has been recognized as non-operating inc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.